A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland

Affiliations

¹ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland. Electronic address: elsa.lorthe@gmail.com.
² Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
³ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
⁴ Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
⁵ Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals, 1205 Geneva, Switzerland.
⁶ Department of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals, 1205 Geneva, Switzerland.
⁷ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁸ Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
⁹ Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, 1205 Geneva, Switzerland; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
¹⁰ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; University Center for General Medicine and Public Health, University of Lausanne, Lausanne, Switzerland.

PMID: 35429994
PMCID: PMC9009838
DOI: 10.1016/S1473-3099(22)00267-5

A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland

Elsa Lorthe et al. Lancet Infect Dis. 2022 Jun.

. 2022 Jun;22(6):767-768.

doi: 10.1016/S1473-3099(22)00267-5. Epub 2022 Apr 14.

Affiliations

¹ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland. Electronic address: elsa.lorthe@gmail.com.
² Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
³ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland.
⁴ Institute of Bioengineering, School of Engineering, École Polytechnique Fédérale de Lausanne, Lausanne, Switzerland.
⁵ Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals, 1205 Geneva, Switzerland.
⁶ Department of Pediatrics, Gynecology & Obstetrics, Pediatric Infectious Disease Unit, Geneva University Hospitals, 1205 Geneva, Switzerland.
⁷ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Institute of Global Health, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
⁸ Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland.
⁹ Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals, 1205 Geneva, Switzerland; Division of Infectious Diseases, Department of Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Microbiology and Molecular Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; Center for Emerging Viral Diseases, Geneva University Hospitals and University of Geneva, Geneva, Switzerland.
¹⁰ Unit of Population Epidemiology, Division of Primary Care Medicine, Geneva University Hospitals, 1205 Geneva, Switzerland; Department of Health and Community Medicine, Faculty of Medicine, University of Geneva, Geneva, Switzerland; University Center for General Medicine and Public Health, University of Lausanne, Lausanne, Switzerland.

PMID: 35429994
PMCID: PMC9009838
DOI: 10.1016/S1473-3099(22)00267-5

No abstract available

PubMed Disclaimer

Conflict of interest statement

This study was approved by the ethics committee of the Canton of Geneva (Project ID 2020-02957). All parents and teachers were informed about the study and gave written informed consent, while children gave verbal assent to participate. The SEROCoV-Schools study was supported by the Federal Office of Public Health, the Private Foundation of the Geneva University Hospitals, the Fondation des Grangettes, the Center for Emerging Viral Diseases, and a SNF NRP (National Research Program) 78 COVID-19 Grant 198412 (to SJM and IE). We declare no competing interests. SEROCoV-Schools Study Group members are listed in the appendix (p 5).

References

1. Viner RM, Koirala A. Daily antigen testing to reduce disruption when schools return. Lancet. 2021;398:1196–1197. - PMC - PubMed
1. Viana R, Moyo S, Amoako DG, et al. Rapid epidemic expansion of the SARS-CoV-2 omicron variant in southern Africa. Nature. 2022;603:679–686. - PMC - PubMed
1. Lorthe E, Bellon M, Michielin G, et al. Epidemiological, virological and serological investigation into a SARS-CoV-2 outbreak (alpha variant) in a primary school: a prospective longitudinal study. medRxiv. 2021 doi: 10.1101/2021.10.26.21265509. published online Nov 24. (preprint). - DOI - PMC - PubMed
1. Song JS, Lee J, Kim M, et al. Serial intervals and household transmission of SARS-CoV-2 omicron variant, South Korea, 2021. Emerg Infect Dis. 2022;28:756–759. - PMC - PubMed
1. Brandal LT, MacDonald E, Veneti L, et al. Outbreak caused by the SARS-CoV-2 omicron variant in Norway, November to December 2021. Euro Surveill. 2021;26 - PMC - PubMed

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland

Affiliations

A SARS-CoV-2 omicron (B.1.1.529) variant outbreak in a primary school in Geneva, Switzerland

Authors

Affiliations

Conflict of interest statement

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous